Skip Nav Destination
Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?
Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience
Thoracic positron emission tomography using18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease
Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)
Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic responders
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain
Correlation of peripheral blood OX40+(CD134+) T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantation: Presented in part at the 42nd Annual Meeting and Exposition of the American Society of Hematology.
Preferential and persistent depletion of CCR5+T-helper lymphocytes with nonlymphoid homing potential despite early treatment of primary HIV infection
Issue Archive
November 15 2001
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein
Richard E. Clark,I. Anthony Dodi,Seran C. Hill,Jennie R. Lill,Geraldine Aubert,Andrew R. Macintyre,Jose Rojas,Audrey Bourdon,Philip L. R. Bonner,Lihui Wang,Stephen E. Christmas,Paul J. Travers,Colin S. Creaser,Robert C. Rees,J. Alejandro Madrigal
REVIEW ARTICLES
Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?
Clinical Trials & Observations
CHEMOKINES
HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin–insensitive chemokine receptor signaling
Manuela Del Corno,Qing-Hua Liu,Dominique Schols,Erik de Clercq,Sandra Gessani,Bruce D. Freedman,Ronald G. Collman
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience
Clinical Trials & Observations
Effie W. Petersdorf,Craig Kollman,Carolyn Katovich Hurley,Bo Dupont,Auayporn Nademanee,Ann B. Begovich,Daniel Weisdorf,Philip McGlave
Thoracic positron emission tomography using18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease
Clinical Trials & Observations
Martin R. Weihrauch,Daniel Re,Klemens Scheidhauer,Sascha Ansén,Markus Dietlein,Stefanie Bischoff,Heribert Bohlen,Jürgen Wolf,Harald Schicha,Volker Diehl,Hans Tesch
Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution
Clinical Trials & Observations
Thomas Nösslinger,Regina Reisner,Elisabeth Koller,Helga Grüner,Heinz Tüchler,Hadwiga Nowotny,Elisabeth Pittermann,Michael Pfeilstöcker
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)
Clinical Trials & Observations
Andrea Bacigalupo,Teresa Lamparelli,Paolo Bruzzi,Stefano Guidi,Paolo Emilio Alessandrino,Paolo di Bartolomeo,Rosa Oneto,Barbara Bruno,Mario Barbanti,Nicoletta Sacchi,Maria Teresa Van Lint,Alberto Bosi,for Gruppo Italiano Trapianti Midollo Osseo (GITMO)
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-β1 and interleukin-10
Ross D. Brown,Belinda Pope,Allan Murray,Warren Esdale,Daniel M. Sze,John Gibson,P. Joy Ho,Derek Hart,Doug Joshua
Expression of CCR-7, MIP-3β, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities
Stefania Parlato,Stefano M. Santini,Caterina Lapenta,Tiziana Di Pucchio,Mariantonia Logozzi,Massimo Spada,Anna Maria Giammarioli,Walter Malorni,Stefano Fais,Filippo Belardelli
Splenectomy of rats selectively reduces lymphocyte function-associated antigen 1 and intercellular adhesion molecule 1 expression on B-cell subsets in blood and lymph nodes
Novica M. Milićević,Birgit Luettig,Christian Trautwein,Torsten Wüstefeld,Michael Mähler,Peter Jecker,Kurt Wonigeit,Jürgen Westermann
NEOPLASIA
Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic responders
Clinical Trials & Observations
Francesca Bonifazi,Antonio de Vivo,Gianantonio Rosti,François Guilhot,Joëlle Guilhot,Elena Trabacchi,Rüdiger Hehlmann,Andreas Hochhaus,Patricia C. A. Shepherd,Juan Luis Steegmann,Hanneke C. Kluin-Nelemans,Josef Thaler,Bengt Simonsson,Andries Louwagie,Josy Reiffers,François Xavier Mahon,Enrico Montefusco,Giuliana Alimena,Joerg Hasford,Sue Richards,Giuseppe Saglio,Nicoletta Testoni,Giovanni Martinelli,Sante Tura,Michele Baccarani,for the European Study Group on Interferon in Chronic Myeloid Leukemia
PHAGOCYTES
RED CELLS
Distinct behavior of mutant triosephosphate isomerase in hemolysate and in isolated form: molecular basis of enzyme deficiency
Ferenc Orosz,Judit Oláh,Marco Alvarez,György M. Keserű,Beáta Szabó,Gábor Wágner,Zoltán Kovári,Margit Horányi,Klára Baróti,Joseph A. Martial,Susan Hollán,Judit Ovádi
TRANSFUSION MEDICINE
TRANSPLANTATION
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain
Clinical Trials & Observations
Giovanni B. Ferrara,Andrea Bacigalupo,Teresa Lamparelli,Edoardo Lanino,Laura Delfino,Anna Morabito,Anna M. Parodi,Cinzia Pera,Sarah Pozzi,Maria P. Sormani,Paolo Bruzzi,Domenico Bordo,Martino Bolognesi,Giuseppe Bandini,Andrea Bontadini,Mario Barbanti,Guido Frumento
BRIEF REPORTS
Correlation of peripheral blood OX40+(CD134+) T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantation: Presented in part at the 42nd Annual Meeting and Exposition of the American Society of Hematology.
Brief Report
Ai Kotani,Takayuki Ishikawa,Yumi Matsumura,Tatsuo Ichinohe,Hitoshi Ohno,Toshiyuki Hori,Takashi Uchiyama
Preferential and persistent depletion of CCR5+T-helper lymphocytes with nonlymphoid homing potential despite early treatment of primary HIV infection
Brief Report
Roman Krzysiek,Annick Rudent,Laurence Bouchet-Delbos,Arnaud Foussat,Claudie Boutillon,Alain Portier,Didier Ingrand,Daniel Sereni,Pierre Galanaud,Liliane Grangeot-Keros,Dominique Emilie,the ANRS O86 PRIMOFERON A Study Group
CORRESPONDENCE
Absence of statistically significant correlation between disparity for the minor histocompatibility antigen HA-1 and outcome after allogeneic hematopoietic cell transplantation
Ming-Tseh Lin,Ted Gooley,John A. Hansen,Li-Hui Tseng,Emily G. Martin,Kentner Singleton,Anajane G. Smith,Eric Mickelson,Effie W. Petersdorf,Paul J. Martin
Increased risk of leukemia relapse with high dose cyclosporine after allogeneic marrow transplantation for acute leukemia: 10 year follow-up of a randomized study
Andrea Bacigalupo,Teresa Lamparelli,Francesca Gualandi,Stefania Bregante,AnnaMaria Raiola,Carmen di Grazia,Alida Dominietto,Chiara Romagnani,Domenico Occhini,Francesco Frassoni,Maria Teresa van Lint
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals